Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Dyah L. Dewi, Soumya R. Mohapatra, Saioa Blanco Cabañes, Isabell Adam, Luis F. Somarribas Patterson, Bianca Berdel, Masroor Kahloon, Loreen Thürmann, Stefanie Loth, Katharina Heilmann, Dieter Weichenhan, Oliver Mücke, Ines Heiland, Pauline Wimberger, Jan Dominik Kuhlmann, Karl-Heinz Kellner, Sarah Schott, Christoph Plass, Michael Platten, Clarissa Gerhäuser, Saskia Trump & Christiane A. Opitz. (2017) Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer. OncoImmunology 6:2.
Read now
Read now
Aitziber Buqué, Norma Bloy, Fernando Aranda, Isabelle Cremer, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy. OncoImmunology 5:6.
Read now
Read now
Articles from other publishers (17)
Chao Meng, Yue Sun & Guoyan Liu. (2023) Establishment of a prognostic model for ovarian cancer based on mitochondrial metabolism-related genes. Frontiers in Oncology 13.
Crossref
Crossref
Penggang Sun, Xinyu Wang, Junzhe Zhong, Daohan Yu, Hanwen Xuan, Tianye Xu, Dan Song, Changxiao Yang, Pandeng Wang, Yuxiang Liu, Xiangqi Meng & Jinquan Cai. (2023) Development and validation of a pyroptosis-related genes signature for risk stratification in gliomas. Frontiers in Genetics 14.
Crossref
Crossref
Florent Peyraud, Jean-Philippe Guegan, Dominique Bodet, Sophie Cousin, Alban Bessede & Antoine Italiano. (2022) Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives. Frontiers in Immunology 13.
Crossref
Crossref
Fahimeh Heidari, Mahboobeh Razmkhah, Vahid Razban & Nasrollah Erfani. (2021) Effects of indoleamine 2, 3‐dioxygenase (IDO) silencing on immunomodulatory function and cancer‐promoting characteristic of adipose‐derived mesenchymal stem cells (ASCs). Cell Biology International 45:12, pages 2544-2556.
Crossref
Crossref
Ana Dolšak, Stanislav Gobec & Matej Sova. (2021) Indoleamine and tryptophan 2,3-dioxygenases as important future therapeutic targets. Pharmacology & Therapeutics 221, pages 107746.
Crossref
Crossref
Qinchuan Wang, Jianchun Gu, Linbo Wang, David W Chang, Yuanqing Ye, Maosheng Huang, Jack A Roth & Xifeng Wu. (2020) Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer. Journal for ImmunoTherapy of Cancer 8:2, pages e000336.
Crossref
Crossref
Hassan Nasser & Maie A. St. John. (2020) The promise of immunotherapy in the treatment of young adults with oral tongue cancer. Laryngoscope Investigative Otolaryngology 5:2, pages 235-242.
Crossref
Crossref
Christiane A. Opitz, Luis F. Somarribas Patterson, Soumya R. Mohapatra, Dyah L. Dewi, Ahmed Sadik, Michael Platten & Saskia Trump. (2019) The therapeutic potential of targeting tryptophan catabolism in cancer. British Journal of Cancer 122:1, pages 30-44.
Crossref
Crossref
Stefano Comai, Antonella Bertazzo, Martina Brughera & Sara Crotti. 2020.
165
218
.
Daniel J. Olson, Rodolfo Gutierrez, Salah Eddine Bentebibel, Randy F. Sweis, Omid Hamid, Adi Diab, Douglas B. Johnson & Jason J. Luke. 2020. Cutaneous Melanoma. Cutaneous Melanoma
1165
1186
.
Brian W. Labadie, Riyue Bao & Jason J. Luke. (2019) Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan–Kynurenine–Aryl Hydrocarbon Axis. Clinical Cancer Research 25:5, pages 1462-1471.
Crossref
Crossref
Daniel J. Olson, Rodolfo Gutierrez, Salah Eddine Bentebibel, Randy F. Sweis, Omid Hamid, Adi Diab, Douglas B. Johnson & Jason J. Luke. 2019. Cutaneous Melanoma. Cutaneous Melanoma
1
22
.
Ming Liu, Xu Wang, Lei Wang, Xiaodong Ma, Zhaojian Gong, Shanshan Zhang & Yong Li. (2018) Targeting the IDO1 pathway in cancer: from bench to bedside. Journal of Hematology & Oncology 11:1.
Crossref
Crossref
Qian Ye, Chenglong Wang, Jie Xian, Ming Zhang, Yijia Cao & Youde Cao. (2018) Expression of programmed cell death protein 1 (PD-1) and indoleamine 2,3-dioxygenase (IDO) in the tumor microenvironment and in tumor-draining lymph nodes of breast cancer. Human Pathology 75, pages 81-90.
Crossref
Crossref
J.-P. Foy, C. Bertolus, M.-C. Michallet, S. Deneuve, R. Incitti, N. Bendriss-Vermare, M.-A. Albaret, S. Ortiz-Cuaran, E. Thomas, A. Colombe, C. Py, N. Gadot, J.-P. Michot, J. Fayette, A. Viari, B. Van den Eynde, P. Goudot, M. Devouassoux-Shisheboran, A. Puisieux, C. Caux, P. Zrounba, S. Lantuejoul & P. Saintigny. (2017) The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade. Annals of Oncology 28:8, pages 1934-1941.
Crossref
Crossref
Donghao Shang, Tie Zheng, Jian Zhang, Ye Tian & Yuting Liu. (2016) Profiling of mRNA and long non-coding RNA of urothelial cancer in recipients after renal transplantation. Tumor Biology 37:9, pages 12673-12684.
Crossref
Crossref
Qiyi Zhao, Pei-pei Wang, Zhan-lian Huang, Liang Peng, Chaoshuang Lin, Zhiliang Gao & Shicheng Su. (2016) Tumoral indoleamine 2, 3-dioxygenase 1 is regulated by monocytes and T lymphocytes collaboration in hepatocellular carcinoma. Oncotarget 7:12, pages 14781-14790.
Crossref
Crossref